Rheumatology

ClinicalAugust 4, 2026

Study on Fecal Microbiota Transplantation for Refractory Rheumatoid Arthritis Initiated

A 24-week randomized, double-blind study is underway to assess the efficacy and safety of oral fecal microbiota transplantation in patients with refractory rheumatoid arthritis.

ClinicalAugust 2, 2026

Study on Tocilizumab and Telitacicept for RA-ILD Treatment Initiated

A 52-week clinical trial is underway to compare tocilizumab, telitacicept, and methotrexate in RA-ILD patients.

ClinicalJuly 30, 2026

Study on Gluten-Free vs Mediterranean Diets in Rheumatoid Arthritis Launched

A new clinical trial is evaluating the effects of gluten-free and Mediterranean diets on rheumatoid arthritis patients over 12 weeks.

ClinicalJuly 29, 2026

Study on Serum Metrnl Levels in PsA and AS Patients to Explore Biomarker Potential

This study evaluates serum Metrnl levels in patients with PsA and AS, aiming to understand its association with disease activity.

ClinicalJuly 28, 2026

Study on ACPA and RA Origins Aims to Uncover Lung Inflammation Links

A study is underway to investigate the relationship between anti-citrullinated protein antibodies and lung inflammation in rheumatoid arthritis patients.

RegulatoryJuly 26, 2026

Post-marketing Surveillance for Xeljanz XR to Evaluate Safety in Rheumatoid Arthritis and Related Conditions

A post-marketing surveillance study for Xeljanz XR will assess its safety and effectiveness in routine clinical practice in Korea.

RegulatoryJuly 25, 2026

FDA Accepts Supplement for Dr Reddy's Allopurinol ANDA071587

The FDA has accepted a supplemental application for Dr Reddy's allopurinol under ANDA071587.

ClinicalJuly 24, 2026

Guizhi-Shaoyao-Zhimu Decoction Modulates IL-17R-MAPK Pathway in Rheumatoid Arthritis

Guizhi-Shaoyao-Zhimu Decoction regulates the IL-17R-MAPK pathway to alleviate symptoms of rheumatoid arthritis.

ClinicalJuly 21, 2026

Eli Lilly's Baricitinib Evaluated for Safety in Pediatric sJIA Patients

Eli Lilly is conducting a study to assess the safety and efficacy of baricitinib in children with systemic juvenile idiopathic arthritis.

ClinicalJuly 19, 2026

Eli Lilly's Eloralintide Shows Promise for Osteoarthritis Knee Pain in Obese Patients

Eli Lilly is conducting two independent studies to evaluate the efficacy and safety of Eloralintide (LY3841136) in adults with knee osteoarthritis and obesity.

ClinicalJuly 15, 2026

Study on Pain Mechanisms in Juvenile Arthritis Launched by Washington University

A new study is investigating the mechanisms of pain in juvenile idiopathic arthritis through psychophysical assessments and biological sampling.

ClinicalJuly 13, 2026

Study on Lung Disease Prevalence in Early Rheumatoid Arthritis Patients

The study aims to characterize lung disease prevalence in early rheumatoid arthritis patients and identify novel biomarkers.

ClinicalJuly 13, 2026

Phase II Study of D-0120 and Allopurinol in Gout by InventisBio

InventisBio is conducting Phase II trial to evaluate the efficacy and safety of D-0120 in combination with Allopurinol for treating gout.

ClinicalJuly 11, 2026

Novartis initiates Phase II trial of MAS825 for Still's Disease

Novartis is conducting Phase II trial to assess the efficacy and safety of MAS825 in patients with Still's disease.

ClinicalJuly 7, 2026

Pilot rTMS Trial for Knee Arthritis Pain and Depression Shows Promise

A pilot trial is investigating the feasibility of rTMS combined with Tai Chi for knee OA pain and depression.

ClinicalJuly 6, 2026

Novartis initiates ascending dose study of PIT565 for rheumatoid arthritis

Novartis is conducting a study to evaluate the safety, tolerability, and pharmacokinetics of PIT565 in rheumatoid arthritis patients.

ClinicalJuly 6, 2026

First Human Study of SBT777101 in Rheumatoid Arthritis by Sonoma Biotherapeutics

Sonoma Biotherapeutics is conducting the first human trial of SBT777101 for rheumatoid arthritis, focusing on safety and effects.

ClinicalJuly 5, 2026

Evaluation of OPTIBIO Tool for Medication Reduction in Rheumatoid Arthritis

A clinical trial is assessing the OPTIBIO predictive tool to guide medication reduction in RA patients in remission.

ClinicalJune 27, 2026

Pilot Study on Osteopathic Intervention for Fibromyalgia Patients Initiated

A pilot study evaluating the efficacy of osteopathic care for fibromyalgia patients has been initiated with 44 participants.

ClinicalJune 21, 2026

Takeda initiates continuation study of Zasocitinib for Psoriatic Arthritis

Takeda is conducting a continuation study of Zasocitinib in adults with Psoriatic Arthritis to assess long-term safety and efficacy.

ClinicalJune 19, 2026

Study on Cardiac Rehabilitation in Hypertensive Rheumatoid Arthritis Patients Initiated

A clinical trial is underway to assess the effects of a 6-week cardiac rehabilitation program in hypertensive patients with controlled rheumatoid arthritis.

ClinicalJune 17, 2026

KSHB002 Trial Shows Equivalence to ORENCIA in PK, Safety, and Immunogenicity for RA

The trial aims to establish the pharmacokinetic equivalence, safety, and immunogenicity of KSHB002 compared to ORENCIA in healthy subjects.

Companies

Assets

Recent signals(22)